Evaluation and pilot implementation of essential interventions for the management of hypertension and prevention of cardiovascular diseases in primary health care in the Republic of Tajikistan

Table 3 Risk factors for intervention and control clinics at baseline and 1-year follow-up

Risk factors	Baseline (N = 467)	Follow-up (N = 618)	Baseline vs. Follow-up Difference^a		Interaction^b
			OR (95 % CI)/difference in means	P-value	P-value
Intervention
Current smoker, % (n/N)	5.4 (14/260)	7.2 (27/374)	2.059 (0.933–4.545)	0.074	0.829
Diabetes, % (n/N)	15.8 (41/260)	19.3 (72/374)	1.354 (0.872–2.102)	0.177	0.973
Newly diagnosed hypertension, % (n/N)	25.4 (66/260)	47.1 (176/374)	2.520 (1.743–3.643)	< 0.001	0.184
History of CVD, % (n/N)	20.0 (52/260)	13.1 (49/374)	0.653 (0.397–1.074)	0.093	0.537
SBP, mean ± SD	146.52 ± 14.25	137.80 ± 12.07	-8.51 (-10.65–6.37)	< 0.001	< 0.001
DBP, mean ± SD	91.80 ± 9.04	86.61 ± 7.85	-5.30 (-6.65–3.96)	< 0.001	< 0.001
Control
Current smoker, % (n/N)	6.8 (14/207)	9.0 (22/244)	1.869 (0.759–4.598)	0.173
Diabetes, % (n/N)	18.8 (39/207)	23.4 (57/244)	1.371 (0.843–2.231)	0.204
Newly diagnosed hypertension, % (n/N)	14.0 (29/207)	19.7 (48/244)	1.565 (0.931–2.631)	0.091
History of CVD, % (n/N)	41.5 (86/207)	37.7 (92/244)	0.767 (0.509–1.156)	0.205
SBP, mean ± SD	142.28 ± 16.58	141.49 ± 14.21	-0.52 (-3.36-2.32)	0.721
DBP, mean ± SD	89.83 ± 8.89	89.85 ± 9.29	0.07 (-1.63-1.77)	0.932

CVD cardiovascular disease; SBP systolic blood pressure; DBP diastolic blood pressure; SD standard deviation; OR odds ratio; CI confidence interval
^a Adjusted for age, gender, and clinic.
^b Interaction for intervention and control clinics adjusted for age, gender, and clinic.

ISSN: 1472-6963